Biography
Dr. Arturo Loaiza-Bonilla, MD, MSEd, FACP is a physician–scientist and oncology executive operating at the intersection of clinical medicine, artificial intelligence, and large-scale clinical research infrastructure.
Clinical interests / subspecialty
Biomarker-driven cancers; immunotherapy; complex trial-based care; clinical trial access/matching infrastructure; neurosymbolic & multi-agent AI platforms
Education & training
Medical School: University of Miami Miller School of Medicine
Residency: St. Luke's-Roosevelt Hospital Center, Columbia University, Internal Medicine
Fellowship: Post-Doctorate Fellow, Hematology and Oncology (University of Miami Miller School of Medicine)
Other training: Master of Medical Education (MSEd), Medical Education (University of Pennsylvania)
Board certifications / licenses
- ABIM - Medical Oncology
- ABIM - Internal Medicine
Professional memberships
ASCO, AACR, ACP (Fellow)
Languages
English (native); French (professional working proficiency); Japanese (elementary proficiency); Spanish (native or bilingual proficiency)
Research areas
AI in clinical trials; neurosymbolic / multi-agent AI architectures; digital health; real-world data activation; precision oncology systems
Clinical research experience
Phase I–III clinical trial leadership and portfolios across oncology networks
Leadership & recognition
- 40 under 40 in Cancer; Philadelphia Business Journal “40 Under 40”; Castle Connolly / Philadelphia Magazine Top Doctors (since 2018)
Publications & media
- 80+ peer-reviewed publications in NEJM AI, JCO, Lancet Oncology, ESMO and JAMA Oncology
- PubMed
Arturo Loaiza-Bonilla reviews Massive Bio content as part of our Medical Review Board, ensuring medical accuracy and clinical currency across our cancer resources.
Content reviewed by Arturo Loaiza-Bonilla
J’ai Guéri d’un Cancer du Poumon Métastasé
SEPTEMBER 2024
What is Stage 4 Breast Cancer?
AUGUST 2024
Cancer Du Foie Stade 4 Symptômes
AUGUST 2024
Symptôme cancer poumon avancé
AUGUST 2024
Cancer Du Foie Symptômes
AUGUST 2024
Cancer Du Poumon Stade 1
JULY 2024
Cancer Des Ganglions
JULY 2024
Leucémie Chroniqu
JUNE 2024
Lymphome de Burkitt
JUNE 2024
Leucémie Symptome
JUNE 2024
Cancer Du Sang
JUNE 2024
Cancer du Foie
MAY 2024
Premiers symptômes cancer du rectum traitement
APRIL 2024
Amelanotic Melanoma
APRIL 2024
Early Stage Skin Cancer
APRIL 2024
Lymphome du manteau
MARCH 2024
Lymphome Folliculaire
MARCH 2024
Myélome Multiple
MARCH 2024
Metastase Au Foie
FEBRUARY 2024
What Is Blood Dyscrasias?
JANUARY 2024
Ce qu’il faut savoir sur le lymphome du manteau?
NOVEMBER 2023
Unlocking New Horizons: Exploring Clinical Trials for Metastatic NSCLC
OCTOBER 2023
Essais cliniques et traitements expérimentaux pour la Leucémie Lymphoblastique Aiguë de l’Enfance
OCTOBER 2023
Déverrouiller de nouveaux horizons : Exploration des essais cliniques pour le cancer du poumon non à petites cellules métastatique (CNPC-M)
OCTOBER 2023